Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to improve care for joint infection patients by listening to their stories

NCT ID NCT07409402

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will interview 63 people, including patients with prosthetic joint infections, their family members, and healthcare professionals, to understand their experiences. The goal is to use this information to create a therapeutic education program that helps patients manage their condition, including antibiotic therapy and rehabilitation. The research is non-interventional and focuses on gathering insights rather than testing a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a therapeutic education program that helps patients better manage their infection, adhere to treatments, and improve their quality of life.
What could go wrong
This is a small, early-stage qualitative study with only 63 participants, so the findings may not apply to all patients. The program is still being developed and tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 63 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients managed in the CRIOAC unit, who underwent surgery for prosthetic joint infection more than one month and less than one year ago and were treated with antibiotic therapy. Relatives or friends designated by the patient, who accompanied them throughout their care, from diagnosis, during and after hospitalisation, at least until the end of the antibiotic therapy. Healthcare professionals (nurses, physiotherapist, psychologists, pharmacists) working for at least one year in the CRIOAC unit.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients : * Age ≥ 18 years * Have undergone surgery \> 1 month and \< 1 year ago for a hip, knee, or shoulder prosthetic implant, and are currently receiving or have received prolonged antibiotic therapy (≥ 6 weeks) * Patients had to agree to sign a consent form to participate in the study. Patient companions : * Age ≥ 18 years * Close relative or friend designated by the patient, who has accompanied them throughout their care journey, from diagnosis, during and after hospitalization, at least until the end of antibiotic treatment * Not opposed to participating in the study Healthcare professionals : * Practicing for ≥ 1 year in a CRIOAC (Reference Center for Osteoarticular Infections) * Role: nurse, physiotherapist, psychologist, pharmacist * Not opposed to participating in the study Exclusion Criteria: Patients : * Do not have proficiency in the French language * Patients with advanced cognitive disorders * Patients with severe depression Patient companions : * Do not have proficiency in the French language * Patients with advanced cognitive disorders * Patients with severe depression Healthcare professionals : -None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prosthetic-joint infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

periprosthetic joint infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prosthetic-joint infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre de Références des Infections-Ostéo Articulaires Complexes CRIOAC

    Paris, France, 75020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.